Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast growth factor 21 (FGF21) is an atypical member of the fibroblast growth factor family, functioning primarily as an endocrine hormone. It is mainly secreted by the liver and plays a crucial role in regulating glucose and lipid metabolism, enhancing insulin sensitivity, and modulating energy expenditure. Elevated levels are observed in metabolic disorders like obesity and type 2 diabetes, making it a promising therapeutic target for these conditions.
Pharmacologic administration of recombinant FGF21 has shown: - Enhanced insulin sensitivity - Decreased triglycerides - Weight loss in animal models
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast Growth Factor 21 (FGF21).